I toksicitetsforsøg med gentagen dosering er anæmi observeret, hvilket sandsynligvis skyldes entakapons jernchelaterende egenskaber.
In repeated dose toxicity studies, anaemia most likely due to iron chelating properties of entacapone was observed.